1052
M. D. Squire et al. / Tetrahedron: Asymmetry 16 (2005) 1047–1053
the addition of a saturated aqueous solution of sodium
bicarbonate (50 mL). The organic products were ex-
tracted from this mixture by the use of methylene chlo-
ride (2 · 50 mL). The combined organic layers were
treated with a saturated aqueous solution of brine
(50 mL), dried over MgSO4 and the solvent removed
by rotary evaporation to afford a yellow oil. The sol-
vents were removed by rotary evaporation and the crude
product was purified by column chromatography
d 10.4, 13.2, 13.4, 19.7, 20.6, 27.2, 35.7, 38.4, 44.9,
45.5, 47.4, 50.1, 51.6, 69.7, 72.4, 79.7, 124.7, 126.1,
127.1, 128.07, 128.09, 128.7, 136.0, 141.3, 149.7, 178.1.
IR (CCl4): 3541, 3038, 1704 (very broad) cmꢀ1. HRMS
(FAB) calcd for C30H39N2O4 (M+1): 491.2910. Found:
491.2915.
4.3.2. (5S,6R,10R,20R,40R,200S,300S)-3-[3-(4-Chlorophen-
yl)-3-hydroxy-2-methylpropionyl]-3,4,5,6-tetrahydro-5-
methyl-4-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-6-phenyl-
(EtOAc/hexanes, 1:9): 88% yield as colourless crystals,
25
D
mp 225–226 ꢁC; ½aꢁ ¼ ꢀ139 (c 1.02, MeOH). 1H
2H-1,3,4-oxadiazin-2-one (8b). Yield 76%; colour-
25
NMR (CDCl3): d 0.68 (d, J = 6.6 Hz, 3H), 0.84 (s,
3H), 0.91 (s, 3H), 1.10–1.25 (m, 1H), 1.61 (t,
J = 7.33 Hz, 3H), 1.20 (s, 3H), 1.47–1.53 (m, 1H),
1.72–1.81 (m, 2H), 1.97–2.02 (m, 2H), 2.80–2.98 (m,
3H), 3.21 (dd, J = 8.1, 5.9 Hz, 1H), 3.80 (quintet,
J = 6.61 Hz, 1H), 6.03 (d, J = 5.5 Hz, 1H), 7.19–7.39
(m, 5H). 13C NMR (CDCl3): d 8.98, 13.0, 13.4, 19.7,
20.5, 27.1, 30.7, 35.6, 38.4, 44.9, 47.3, 49.8, 51.3, 69.8,
79.1, 124.7, 127.9, 128.5, 136.3, 149.7, 175.0. IR
(CCl4): 2928, 2879, 1731(broad), 1132 cmꢀ1. Anal.
Calcd for C23H32N2O3: C, 71.84; H, 8.39; N, 7.29.
Found: C, 71.76; H, 8.41; N, 7.37.
less crystals, mp 134–135 ꢁC; ½aꢁ ¼ ꢀ113 (c 0.65,
D
MeOH). 1H NMR (CDCl3): d 0.69 (d, J = 7.0 Hz,
3H), 0.85 (s, 3H), 0.94 (s, 3H), 1.04 (d, J = 7.0 Hz,
3H), 1.12–1.28 (m, 2H), 1.22 (s, 3H), 1.74–1.84 (m,
3H), 1.96–2.06 (m, 2H), 3.24 (dd, J = 7.7, 5.5 Hz, 1H),
3.45 (br s, 1H), 3.84 (quintet, J = 6.7 Hz, 1H), 3.89
(dq, J = 2.2, 7.0 Hz, 1H), 5.25 (d, J = 2.2 Hz, 1H), 6.07
(d, J = 5.9 Hz, 1H), 7.18 (d, J = 7.3 Hz, 1H), 7.26 (s,
1H), 7.26–7.42 (m, 7H). 13C NMR (CDCl3): d 10.4,
13.1, 13.3, 19.7, 20.5, 27.1, 35.6, 38.4, 44.8, 45.4, 47.3,
50.0, 51.5, 69.6, 71.9, 79.6, 124.6, 127.6, 128.0, 128.1,
128.6, 132.7, 135.8, 139.9, 149.7, 177.6. IR (CCl4):
3500, 1706, 754 cmꢀ1
. HRMS (FAB) calcd for
C30H38ClN2O4 (M+1): 525.2520. Found: 525.2536.
4.3. General procedure for the formation of the aldol
adducts
4.3.3. (5S,6R,10R,20R,40R,200S,300S)-3,4,5,6-Tetrahydro-
3-(3-hydroxy-2-methyl-3-naphthalen-2-yl-propionyl)-5-
methyl-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-6-phenyl-
In a flame-dried, nitrogen purged, 25 mL round bottom
flask, the N3-propionylated oxadiazinone (0.625 g,
1.63 mmol) was dissolved in THF (5.5 mL). To this
solution was added titanium tetrachloride (0.20 mL,
1.7 mmol) by syringe. The temperature of the solution
was lowered to ꢀ78 ꢁC after 1 h of induction time. Tri-
ethylamine (0.25 mL, 1.7 mmol) was added to the solu-
tion and the system allowed to warm to 0 ꢁC over
approximately 30 min. Once the solution had reached
0 ꢁC, the aldehyde (0.198 mL, 1.95 mmol) was added
to solution by syringe and the system was allowed to
warm to room temperature and run overnight. The reac-
tion was quenched by the addition of a saturated aque-
ous solution of ammonium chloride (25 mL). The
organic products were extracted from this mixture by
the use of ethyl acetate (2 · 25 mL). The combined
organic layers were treated with a saturated aqueous solu-
tion of brine (25 mL), dried over MgSO4 and the solvent
removed by rotary evaporation to afford a yellow oil.
The solvents were removed by rotary evaporation and
the crude product was purified by column chromatogra-
phy (EtOAc/hexanes, 1:9).
4-2H-1,3,4-oxadiazin-2-one 8c. Yield 88%; colourless
25
crystals, mp 140–141 ꢁC; ½aꢁ ¼ ꢀ122 (c 1.33, MeOH).
D
1H NMR (CDCl3): d 0.71 (d, J = 7.0 Hz, 3H), 0.82 (s,
3H), 0.93 (s, 3H), 1.08 (d, J = 7.0 Hz, 3H), 1.12–1.25
(m, 2H), 1.23 (s, 3H), 1.48–1.56 (m, 1H), 1.75–1.83 (m,
3H), 1.98–2.06 (m, 1H), 3.25 (dd, J = 8.1, 5.5 Hz, 1H),
3.60 (br s, 1H), 3.84 (quintet, J = 6.7 Hz, 1H), 4.12
(dq, J = 2.0, 7.2 Hz 1H), 5.45 (s, 1H), 6.10 (d,
J = 5.5 Hz, 1H), 7.18 (d, J = 7.3 Hz, 1H), 7.26–7.50
(m, 7H), 7.55 (d, J = 8.4 Hz, 1H), 7.83–7.89 (m, 2H),
7.96 (s, 1H). 13C NMR (CDCl3): d 10.5, 13.2, 13.4,
19.7, 20.4, 27.1, 35.7, 38.4, 44.9, 45.3, 47.3, 50.0, 51.6,
69.6, 72.5, 79.6, 124.3, 124.7, 125.0, 125.6, 125.8,
127.5, 127.7, 128.00, 128.03, 128.6, 132.7, 133.1, 135.9,
138.7, 149.7, 178.0. IR (CCl4): 3482, 1729, 1696 cmꢀ1
.
HRMS (ESI) calcd for C34H41N2O4 (M+1): 541.3066.
Found: 541.3066.
4.3.4. (5S,6R,10R,20R,40R,200S,300S)-3,4,5,6-Tetrahydro-
3-(3-hydroxy-2,4,4-trimethyl-pentanoyl)-5-methyl-6-phen-
yl-4-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-2H-1,3,4-
4.3.1. (5S,6R,10R,20R,40R,200S,300S)-3,4,5,6-Tetrahydro-
3-(3-hydroxy-2-methyl-3-phenylpropionyl)-5-methyl-6-
phenyl-4-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-2H-1,3,4-
oxadiazin-2-one 8d. Yield 88%; colourless crystals, mp
25
D
149–150 ꢁC; ½aꢁ ¼ ꢀ135 (c 1.77, MeOH). 1H NMR
(CDCl3): d 0.69 (d, J = 7.2 Hz, 3H), 0.85 (s, 3H), 0.93
(s, 3H), 1.00 (s, 9H), 1.11–1.17 (m, 2H), 1.21 (d,
J = 7.0 Hz, 3H), 1.22 (s, 3H), 1.26–1.32 (m, 2H), 1.47–
1.54 (m, 1H), 1.73–1.82 (m, 2H), 1.96–2.04 (m, 1H),
3.21 (dd, J = 8, 6 Hz, 1H), 3.65 (s, 1H), 3.81 (quintet,
J = 6.8 Hz, 1H), 4.19 (q, J = 6.6 Hz, 1H), 6.05 (d,
J = 5.9 Hz, 1H), 7.19 (d, J = 7.3 Hz, 2H), 7.30–7.41
(m, 3H). 13C NMR (CDCl3): d 12.4, 13.3, 13.7, 14.1,
19.7, 20.6, 22.6, 27.1, 27.2, 31.6, 35.5, 35.7, 38.5, 39.9,
44.9, 47.4, 50.2, 51.6, 69.7, 79.7, 124.8, 128.1, 128.7,
136.1, 149.6, 179.7. IR (CCl4): 3450, 1722 cmꢀ1. HRMS
oxadiazin-2-one 8a. Yield 67%; colourless crystals,
25
D
mp 111–112 ꢁC; ½aꢁ ¼ ꢀ129 (c 0.47, MeOH). 1H
NMR (CDCl3): d 0.70 (d, J = 7.0 Hz, 3H), 0.85 (s,
3H), 0.94 (s, 3H), 1.07 (d, J = 7.0 Hz, 3H), 1.10–1.28
(m, 2H), 1.22 (s, 3H), 1.49–1.70 (m, 2H), 1.74–1.83 (m,
2H), 1.98–2.05 (m, 1H), 3.24 (dd, J = 5.9, 2.2 Hz, 1H),
3.44 (br s, 1H), 3.83 (quintet, J = 6.7 Hz, 1H), 4.00
(dq, J = 2.6, 7.0 Hz, 1H), 5.28 (d, J = 2.2 Hz, 1H), 6.07
(d, J = 5.9 Hz, 1H), 7.18 (d, J = 7.3 Hz, 1H), 7.20–7.40
(m, 8H), 7.49 (d, J = 7.7 Hz, 1H). 13C NMR (CDCl3):